Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
What to Know About the No Surprises Act
What to Know About the No Surprises Act
Advocacy Efforts During the COVID-19 Pandemic
Advocacy Efforts During the COVID-19 Pandemic
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma
Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma
Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations in patients with metastatic castration-resistant prostate cancer
Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations in patients with metastatic castration-resistant prostate cancer
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Helping Ensure Adequate Tissue Sampling Within the MDT
Helping Ensure Adequate Tissue Sampling Within the MDT
Pre-Testing: Working Together Toward Testing
Pre-Testing: Working Together Toward Testing
Interpreting Test Results and Making the Treatment Decision Within the MDT
Interpreting Test Results and Making the Treatment Decision Within the MDT
Advocate for the Pathologist Within the MDT
Advocate for the Pathologist Within the MDT
